Although abnormalities in mitochondrial (mt) biomarkers are reported in HIV-infected children and/or antiretroviral treatment (ART), mt function in children with sustained viral suppression after initiation of ART in early life has not been described. Here we examined multiple markers of mt function in HIV-infected children on ART.
We selected a cross-sectional sample of 120 HIV-infected children with viral load < 400 copies/mL and 60 age-matched uninfected controls enrolled in a cohort study in Johannesburg, South Africa. Half the HIV-infected children initiated ART <6 months of age, and the others between 6-24 months. Markers of mt function were measured when children were suppressed on lopinavir/ritonavir plus nucleoside reverse transcriptase inhibitors (3TC and D4T or ABC). Complex IV (CIV) and citrate synthase (CS) activity (ODS units) were measured by spectrophotometry, and relative mtDNA content (copies/nDNA) was measured by real-time PCR. The ratio of CIV/CS was categorized as normal (>0.22 [75th quantile]) or impaired (≤0.22). Mt markers were compared by HIV status, age at ART initiation, duration of ART, and anthropometric characteristics.
Median age was 6.8 years, ART duration ranged from 3 to 8 years in HIV-infected children. Compared to uninfected controls, mean CIV (1.40 vs. 1.76) and CS (8.45 vs. 9.29) were significantly reduced in HIV-infected (Table). Infected children also had increased risk of impaired CIV/CS ratio compared to uninfected controls (OR=2.33, 95%CI: 1.09-4.94). We observed a bimodal distribution of mtDNA in both groups and stratified children into those with lower (<12 copies/nDNA) or higher quantity mtDNA (>50 copies/nDNA). MtDNA in HIV-infected children was decreased compared with uninfected children within both lower quantity (3.36 and 4.63) and higher quantity (425 and 849) subsets. In HIV-infected children, CIV was significantly decreased in children who were stunted (height-for-age Z-score <-2) vs. children who were not stunted (1.20 vs. 1.43). CIV and mtDNA increased from 1.18 to 1.50 and 258 to 541, respectively with longer duration on ART (≥5 yrs). Earlier initiation of ART had no significant impact on CIV, CS and mtDNA content compared with later initiation.
Despite early treatment and prolonged viral suppression, mt dysfunction is detectable in HIV-infected children particularly among those with stunting. Whether mt function normalizes with continued time on ART requires further longitudinal studies.